register

News - Pharmaceuticals

World-first technique to improve cancer treatments

Health Industry Hub | August 26, 2020 |

Pharma News: An innovative technique to improve cancer treatments using tumour biopsies less than 30 minutes after they’re taken has been developed at The University of Queensland.  

The ‘Drug uptake in ex Vivo tumours’ technique was developed after researchers found fresh patient tumour biopsies responded differently to treatments than the tissue cultures traditionally used.

Its inventor, UQ Diamantina Institute’s Dr Fiona Simpson, said it could be used to show how long antibodies stayed active in patients, or when antibodies were taken into the tumour where they’re destroyed.

“The technique will significantly help pharmaceutical and technology companies design future cancer drugs,” Dr Simpson said.

“Until now, scientists have only looked at how cancer drugs interact with tissue culture, not fresh tumours.

“Applying medications to tissue culture doesn’t always work because the immune system responds differently in a body.

“I thought it was pretty obvious that we should test cancer drugs on actual tumours, but people kept telling my research team that it wouldn’t work!”

The technique includes a step-by-step process to help drug companies and researchers better understand how drugs interact with patients, and respond to targeted treatments.

“We’ve created a comprehensive process, including detailed videos on tumour extraction and drug-testing processes, for researchers around the world to use,” she said.

“The technique is useful for all types of cancers, and we’re very excited about its possibilities.”

The research was published in Cell Press’ STAR Protocols.


News - Pharmaceuticals

New vaccine guidelines risk further decline in vaccine uptake

New vaccine guidelines risk further decline in immunisation

Health Industry Hub | August 11, 2026 |

The intensifying political and public scrutiny of Dr Anthony Fauci has become emblematic of a wider struggle over trust in […]

More


News - Pharmaceuticals

The weight of the wait: GLP-1 boom hits PBS roadblock

The weight of the wait: GLP-1 boom hits PBS roadblock

Health Industry Hub | August 11, 2026 |

More than one million Australians have been dispensed a GLP-1 receptor agonist over the past five years, accelerating the emergence […]

More


News - MedTech & Diagnostics

As insurer blame game escalates, patients miss out on the promise of private health

As insurer blame game escalates, patients miss out on the promise of private health

Health Industry Hub | August 11, 2026 |

The Age and Sydney Morning Herald’s investigation into the Prescribed List (PL) and the pricing of medical devices has drawn […]

More


Leadership & Management

David Henderson appointed Takeda Oceania Country Head

David Henderson appointed Takeda Oceania Country Head

Health Industry Hub | August 10, 2026 |

David Henderson has been appointed Country Head for Takeda Oceania, succeeding Dave Pearce, as the pharmaceutical company continues to reshape […]

More


This content is copyright protected. Please subscribe to gain access.